ClinicalTrials.Veeva

Menu

A Randomized Control Study of Anti-Adhesion Agent After Colorectal Surgery

T

Taipei Medical University

Status

Enrolling

Conditions

Adhesion

Treatments

Device: Use 4DryField

Study type

Interventional

Funder types

Other

Identifiers

NCT05580471
N202106033

Details and patient eligibility

About

This project is to evaluate the difference of post-operation adhesion severity and adhesion area of patient received 4DryField after colorectal surgery.

Full description

This proposal will investigate the effect of the newly anti-adhesive agent 4DryField. Stoma creation is common in complicated colorectal disease. Hartman procedure (End colostomy) is used in patients advanced rectal cancer or severe diverticulitis. Loop colostomy or ileostomy is used in patients need stool diversion for prevent leakage related infection.

4DryField is a powder consisting of sterile hydrophilic microparticles, which is anufactured from highly purified potato starch in a complex process. A unique starch-based medical device is 4DryField® PH (4DryField; PlantTec Medical GmbH, Germany) as it is the only product proven to provide hemostasis and prevent the formation of adhesions. In rat model, the 4DryField acheieve the significant adhesion prevention effectiveness. In gynecologic surgery, 4DryField showed effective adhesion prevention as confirmed at second look laparoscopy. The gel is easilier to applied in the uneven surface of pelvic cavity and peristomy area than other manufacture. The indication of adhesion prevention is approved by TFDA.

Enrollment

40 estimated patients

Sex

All

Ages

20 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing colorectal resection and temporary stoma

Exclusion criteria

    • Pregnancy, child, psychiatric disorder, behavior disorder, and prisoner. And those patients can't follow the protocol

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Use 4DryField
Experimental group
Description:
One group use 4DryField before wound closure.
Treatment:
Device: Use 4DryField
Not Use 4DryField
No Intervention group
Description:
One group do not use 4DryField before wound closure.

Trial contacts and locations

1

Loading...

Central trial contact

Tungcheng Chang, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems